Overview

  • Product namePHCCC
  • Description
    Selective allosteric potentiator at mGlu4. Also group I antagonist.
  • Biological descriptionSelective allosteric potentiator of mGlu4. Anti-Parkinson and anxiolytic effects in vivo. Also antagonist at Group I metabotropic receptors.
  • Purity> 98%

Properties

    References for PHCCC (ab120043)

    This product has been referenced in:
    • Stachowicz K  et al. Anxiolytic-like effects of PHCCC, an allosteric modulator of mGlu4 receptors, in rats. Eur J Pharmacol 498:153-6 (2004). Read more (PubMed: 15363989) »
    • Marino MJ  et al. Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatment. Proc Natl Acad Sci U S A 100:13668-73 (2003). Read more (PubMed: 14593202) »

    See all 3 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120043.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"